Manalao, Ashminah L.

HRN: 27-17-28  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2025
CEFTRIAXONE 1G (VIAL)
05/21/2025
06/04/2025
IV
1.4g
Q12
TC PMBO
Waiting Final Action 
05/21/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/21/2025
06/04/2025
IV
280
Q8
TC PMBO
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: